Pfizer Reaffirms FY26 Adjusted EPS Range $2.80 to $3, Revenue Range $59.5B - $62.5B

Benzinga Newsdesk www.benzinga.com Neutral 92.9%

Neg 0% Neu 92.9% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/78003/000007800326000087/pfe-20260618.htm

Comments

No comments yet. Be the first!